Lipoprotein(a) as a cardiovascular risk factor: current status
Clicks: 2
ID: 291643
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
0.3
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #155 of 310 articles by views in european heart journal
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 310 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AimsThe aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies.
| Reference Key |
openalex_W2098890974
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray, Jan Borén, Felicita Andreotti, Gerald F. Watts, Henry N. Ginsberg, Pierre Amarenco, Alberico L. Catapano, Olivier Descamps, Edward A. Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, L. Masana, Željko Reiner, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen |
| Journal | european heart journal |
| Year | 2010 |
| DOI |
10.1093/eurheartj/ehq386
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.